Enhertu recently received Breakthrough Therapy Designation, accelerating development and review for this critical patient population
SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
If approved, Ameluz would become the first and only photodynamic therapy (PDT) photosensitizer for sBCC in the US
Achondroplasia is a genetic condition driven by FGFR3 that affects more than stature alone
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
Hologic has been at the forefront of cervical cancer screening for decades
The company maintained a competitive ARPOB while steadily improving occupancy, driven by higher patient volumes and efficient capacity utilization
The Chennai facility will manufacture high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other minimally invasive devices
Subscribe To Our Newsletter & Stay Updated
